User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

Articles from Fool.com

RSS feedDisplaying articles 1 - 10 of most recent articles

Coming Soon: The First Department Store Bankruptcy Since the Great Recession? Bon-Ton Stores is dangerously close to becoming the first department store casualty of the retail apocalypse.
Fool.com | 4 hours, 32 minutes ago | comment? | recommend
Why JD.com Is Your Ticket to Investing in the Growth of E-Commerce in China The company is already leading this fast-growing market.
Fool.com | 4 hours, 32 minutes ago | comment? | recommend
Investors Can Expect 2 Things From These 3 Oil Giants in 2018 There's a lot to like about what Hess, Suncor Energy, and Anadarko have planned for next year.
Fool.com | 4 hours, 34 minutes ago | comment? | recommend
As Warren Buffett Throws in the Towel, What's Next for IBM? While Berkshire Hathaway and Warren Buffett continue to trim their position in IBM, is this an opportunity for long-term investors?
Fool.com | 4 hours, 36 minutes ago | comment? | recommend
Younger Workers Expect to Mostly Fund Their Own Retirement -- and That's a Good Thing Talk about a solid reality check.
Fool.com | 5 hours, 21 minutes ago | comment? | recommend
What's an Alaska Permanent Fund Dividend, and How Can I Get It? Learn the basics of this valuable benefit.
Fool.com | 5 hours, 37 minutes ago | comment? | recommend
GameStop Corp. Earnings: What to Watch A preview of the video game retailer's upcoming earnings report.
Fool.com | 5 hours, 52 minutes ago | comment? | recommend
Best Buy: Coca-Cola, McDonald's, or Verizon? Soda, fast food, or smartphones? We stack the three Dow giants against one another as investment candidates.
Fool.com | 6 hours, 52 minutes ago | comment? | recommend
Whats Next for Nektar Therapeutics? This midcap biotech stock is flying higher and given how many drugs are in its pipeline, it could only be getting started.
Fool.com | 7 hours, 12 minutes ago | comment? | recommend
Is Loxo Oncology's Deal With Bayer Bad News? Investors appear discouraged by the company's decision to license its lead product.
Fool.com | 7 hours, 17 minutes ago | comment? | recommend